Alliqua BioMedical is a regenerative technologies company which commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. It markets MIST Ultrasound Healing Therapy, a painless, noncontact, low-frequency ultrasound to promote healing, Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix that are human biologic regenerative technologies, and TheraBond 3D Antimicrobial Barrier Systems that promotes an optimal wound healing by creating an antimicrobial barrier that helps protect against infection. The Company also provides contract manufacturing services, including the development, manufacture, and market of high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics.

Company Growth (employees)
Type
Public
HQ
Yardley, US
Founded
1997
Size (employees)
81 (est)
Alliqua was founded in 1997 and is headquartered in Yardley, US

Key People/Management at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

COO
Brian Posner

Brian Posner

Chief Financial Officer
Phillip Forman

Phillip Forman

Executive VP Clinical Affairs
Nino Pionati

Nino Pionati

Chief Strategy and Marketing Officer
Gregory Robb

Gregory Robb

VP Operations

Alliqua Office Locations

Alliqua has an office in Yardley
Yardley, US (HQ)
1010 Stony Hill Road, Suite 200
Show all (1)

Alliqua Financials and Metrics

Alliqua Financials

Alliqua's revenue was reported to be $18.2 m in FY, 2016
USD

Net income (Q2, 2017)

(4.2 m)

EBIT (Q2, 2017)

(3.8 m)

Market capitalization (16-Feb-2018)

8.2 m

Cash (30-Jun-2017)

2.3 m
Alliqua's current market capitalization is $8.2 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

1.8 m4.8 m15 m18.2 m

Revenue growth, %

166%214%21%

Cost of goods sold

2.1 m3.3 m6 m6.7 m

Gross profit

(299.3 k)1.5 m9 m11.6 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

438 k

Cost of goods sold

586.7 k631.7 k836.7 k915.8 k1.2 m1.4 m1.7 m1.8 m1.6 m1.8 m1.7 m1.9 m

Gross profit

(148.7 k)

Gross profit Margin, %

(34%)
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

12.1 m16.8 m26.1 m5.6 m

Accounts Receivable

156.8 k968.6 k2.5 m2.8 m

Inventories

88.4 k477.8 k942 k2.7 m

Current Assets

12.8 m19.6 m32.7 m11.8 m
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

9.6 m23.8 m19.9 m10.9 m35.8 m30.7 m17 m12.6 m10.7 m2.4 m2.3 m

Accounts Receivable

164.1 k474.4 k715.6 k1.4 m2.3 m2.4 m2.5 m2.5 m2.7 m2.9 m3.6 m

Inventories

501.1 k940.7 k1.1 m1.6 m2.9 m3.5 m3.5 m3.1 m3.2 m2.6 m2.8 m

Current Assets

10.5 m25.3 m22 m14.8 m41.7 m37.5 m24.1 m23.5 m17.6 m8.3 m8.9 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(22 m)(25.4 m)(26 m)(28.2 m)

Depreciation and Amortization

674.2 k2.9 m4.2 m

Accounts Receivable

(48 k)968.6 k(779.5 k)(281 k)

Inventories

105.3 k477.8 k(257.3 k)(113 k)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(7 m)(9 m)(6 m)(5.1 m)(7.7 m)(7 m)(7.1 m)(7.7 m)5.2 m(8.6 m)(7 m)

Depreciation and Amortization

492.9 k

Accounts Receivable

(35.7 k)474.4 k715.6 k1.4 m2.3 m2.4 m2.5 m2.5 m2.7 m2.9 m

Inventories

18 k
Y, 2017

Financial Leverage

1.7 x
Show all financial metrics

Alliqua Market Value History

Alliqua's Web-traffic and Trends

Alliqua Online and Social Media Presence

Alliqua Company Life and Culture

You may also be interested in